SEATTLE, WA — June 23, 2002 –
Botox (botulinum toxin type A ) injections given every three months appear to prevent up to 92 percent of debilitating headaches in patients who do not respond to other medications, researchers reported here June 21 at the annual meeting of the American Headache Society.
“The side-effects of current medications used for migraine can have difficult side-effects. Now we have a new treatment for severe headache without those problems. It is an important development,” said Stephen Silberstein, MD, president of the American Headache Society and professor of neurology at Thomas Jefferson Medical School in Philadelphia, Pennsylvania.
Though not yet approved for headache treatment, Botox was approved by the Food and Drug Administration (FDA) for other medical uses. Migraine headaches affect about 17 percent of women and 6 percent of men in the United States. About 5 percent of the population has chronic daily headache.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!